These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15077158)
1. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158 [TBL] [Abstract][Full Text] [Related]
2. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184 [TBL] [Abstract][Full Text] [Related]
3. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746 [TBL] [Abstract][Full Text] [Related]
5. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
8. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258 [TBL] [Abstract][Full Text] [Related]
9. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616 [TBL] [Abstract][Full Text] [Related]
10. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
11. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848 [TBL] [Abstract][Full Text] [Related]
12. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788 [TBL] [Abstract][Full Text] [Related]
13. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084 [TBL] [Abstract][Full Text] [Related]
14. Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells. Malki S; Bibeau F; Notarnicola C; Roques S; Berta P; Poulat F; Boizet-Bonhoure B Cancer Lett; 2007 Oct; 255(2):182-93. PubMed ID: 17532558 [TBL] [Abstract][Full Text] [Related]
15. Expression of transcription factor Sox9 in rat L6 myoblastic cells. Matsushita T; Matsui N; Fujioka H; Kubo S; Kuroda R; Kurosaka M; Yoshiya S Connect Tissue Res; 2004; 45(3):164-73. PubMed ID: 15512770 [TBL] [Abstract][Full Text] [Related]
16. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related]
17. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. James CG; Woods A; Underhill TM; Beier F BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Appleton CT; Usmani SE; Bernier SM; Aigner T; Beier F Arthritis Rheum; 2007 Nov; 56(11):3693-705. PubMed ID: 17968906 [TBL] [Abstract][Full Text] [Related]
19. Influence on spatiotemporal patterns of a male-specific Sox9 activation by ectopic Sry expression during early phases of testis differentiation in mice. Kidokoro T; Matoba S; Hiramatsu R; Fujisawa M; Kanai-Azuma M; Taya C; Kurohmaru M; Kawakami H; Hayashi Y; Kanai Y; Yonekawa H Dev Biol; 2005 Feb; 278(2):511-25. PubMed ID: 15680367 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]